"Terrible outcome": Leading scientist says CGT change will kill innovation 🔬💸

Award winning scientist and Managing Director of SYNthesis BioVentures Andrew Wilks tells James Willis how Australia's growing biotech sector is at risk of being stifled due to the government's CGT changes. 

See omnystudio.com/listener for privacy information.